Dopamine D2 receptor suppresses gastric cancer cell invasion and migration via inhibition of EGFR/AKT/MMP-13 pathway. [electronic resource]
Producer: 20170407Description: 113-120 p. digitalISSN:- 1878-1705
- Antineoplastic Agents -- therapeutic use
- Carcinogenesis -- drug effects
- Cell Line, Tumor
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Dopamine -- therapeutic use
- Epidermal Growth Factor -- metabolism
- ErbB Receptors -- metabolism
- Gene Expression Regulation, Neoplastic -- drug effects
- Humans
- Matrix Metalloproteinase 13 -- metabolism
- Oncogene Protein v-akt -- metabolism
- Receptors, Dopamine D2 -- agonists
- Signal Transduction -- drug effects
- Stomach Neoplasms -- drug therapy
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.